Chandra Bhati

Chandra Bhati

Auto-generated profile, based on publicly available information

Chandra Bhati

Department of Internal Medicine, University of Maryland, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2019 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
GGGaurav Gupta
Gaurav Gupta
IYIdris Yakubu
Idris Yakubu
CBChandra S. Bhati
Chandra S. Bhati
YZYiran Zhang
Yiran Zhang
LKLe Kang
Le Kang
RSRichard K. Sterling
Richard K. Sterling
We conducted an adaptive design single‐center pilot trial between Oct’2017 to Nov’2018 to determine the safety and efficacy of ultra‐short‐term peri‐operative pangenotypic direct acting antiviral (DAA) prophylaxis for deceased hepatitis C virus (HCV)‐nucleic acid test (NAT) positive donors to HCV negative kidney recipients (D+/R‐). In Group 1, ten patients received one dose of SOF/VEL (sofusbuvir/velpatasvir) pre‐transplant and one dose on post‐transplant Day 1. In Group 2A (N=15) and the post‐trial validation (Group 2B; N=25) phase, patients received two additional SOF/VEL doses (total 4) on Days 2 and 3 post‐transplant. Development of post‐transplant HCV transmission triggered 12‐week DAA therapy. For available donor samples (N=27), median donor viral load was 1.37E+06 IU/mL [Genotype (GT)1a: 70%; GT2: 7%; GT3: 23%]. Overall viral transmission rate was 12% [6/50; Group 1:30% (3/10); Group 2A:13% (2/15); Group 2B:4% (1/25)]. For the six viremic patients, five (83%) achieved sustained virologic response (3 with 1st line DAA therapy; and two after re‐treatment with 2nd line DAA). At a median follow‐up of 8 months post‐transplant, overall patient and allograft survivals were 98%, respectively. The 4‐day strategy reduced viral transmission to 7.5% (3/40; 95% CI: 1.8‐20.5%) and could result in avoidance of prolonged post‐transplant DAA therapy for most D+/R‐ transplants.

1 January 2011 in International Journal of Surgery
Verified
Journal Article
Closed access
GMGareth Morris-Stiff
Gareth Morris-Stiff
ATAppou Tamijmarane
Appou Tamijmarane
YTYu-Meng Tan
Yu-Meng Tan
ISIestyn Shapey
Iestyn Shapey
CBChandra Bhati
Chandra Bhati
DMDarius F. Mirza
Darius F. Mirza
Whilst there are theoretical benefits from pre-operatively draining the biliary tree prior to pancreatoduodenectomy (PD), the current literature does not support this intervention. The aim of this study was to explore the relationship between pre-operative stenting, bactibilia and outcome in a large United Kingdom tertiary referral practice. Patients undergoing PD were identified from a prospectively maintained database. The presence or absence of a stent prior to PD, and the results of bile cultures taken at PD were related to the subsequent post-operative course and the development of complications. 280 patients underwent PD for periampullary malignancies, all of whom presented with jaundice. 118 patients were stented prior to referral (98 ERCP, 20 PTC). Bile cultures were positive more frequently in the stent group (83% vs. 55%; p = 0.000002) and bactibilia was more common after ERCP than PTC (83% vs. 56%; p = 0.006). The overall prevalence of complications was 54% in the stented and 41% in the non-stented group (p = 0.03) with statistical significance achieved for pancreatic leak (p = 0.013) and haemorrhagic complications (p = 0.03). Comparing stent with no stent, there as no difference in the 30-day mortalities (8.5% vs. 6.8%; p = 0.6) or the 1-year mortality rates (35% vs. 28%; p = 0.21). Mortality rates in the infection versus no infection groups were comparable at 30 days (8.5% vs. 5.5%; p = 0.21), and at 1 year (30.7% vs. 26.4%; p = 0.25). Pre-operative stent insertion prior to PD is associated with increased morbidity but not mortality and this is greatest for stents placed at ERCP.

16 February 2007 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
PJP. Jethwa
P. Jethwa
EBE. Breuning
E. Breuning
CBC. Bhati
C. Bhati
JBJ. Buckles
J. Buckles
DMD. Mirza
D. Mirza
SBS. Bramhall
S. Bramhall

1 February 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
MSMohammad Shadab Siddiqui
Mohammad Shadab Siddiqui
MIMichael O. Idowu
Michael O. Idowu
KSKatharine Stromberg
Katharine Stromberg
ASAdam Sima
Adam Sima
ELEmily Lee
Emily Lee
CBChandra S. Bhati
Chandra S. Bhati

31 July 2009 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
GMG. Morris-Stiff
G. Morris-Stiff
EAE. Alabraba
E. Alabraba
YTY.-M. Tan
Y.-M. Tan
ISI. Shapey
I. Shapey
CBC. Bhati
C. Bhati
DMDarius F. Mirza
Darius F. Mirza

28 May 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
Al-Faraaz KassamAl-Faraaz Kassam
Al-Faraaz Kassam
ACAlexander R. Cortez
Alexander R. Cortez
LWLeah K. Winer
Leah K. Winer
KCKendra D. Conzen
Kendra D. Conzen
AEAshraf El-Hinnawi
Ashraf El-Hinnawi
RQRalph Cutler Quillin
Ralph Cutler Quillin
Burnout among surgeons has been attributed to increased workload and decreased autonomy. Although prior studies have examined burnout among transplant surgeons, no studies have evaluated burnout in abdominal transplant surgery fellows. The objective of our study was to identify predictors of burnout and understand its impact on personal and patient care during fellowship. A survey was sent to all abdominal transplant surgery fellows in an American Society of Transplant Surgeons‐accredited fellowship. The response rate was 59.2% (n=77) and 22.7% (n=17) of fellows met criteria for burnout. Fellows with lower grit scores were more likely to exhibit burnout compared to fellows with higher scores (3.6 vs 4.0, p=0.026). Those with burnout were more likely to work over 100 hours per week (58.8% vs 27.6%, p=0.023), have severe work‐related stress (58.8% vs 22.4%, p=0.010), consider quitting fellowship (94.1% vs 20.7%, p<0.001), or make a medical error (35.3% vs 5.2%, p=0.003). This national analysis of abdominal transplant fellows found that burnout rates are relatively low, but few fellows engage in self‐care. Personal and program‐related factors attribute to burnout and it has unacceptable effects on patient care. Transplant societies and fellowship programs should develop interventions to give fellows tools to prevent and combat burnout.